Lithium
Active substance: lithium
SOLUTION · LITHIUM CITRATE 8 meq/5mL
United StatesActive
Marketing holder: Saptalis Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LITHIUM CITRATE · 8 meq/5mL
Registration
- Registration number
- 71656-072
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 71656-072 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71656-072 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71656-072 · Verified 2026-10-09 · open in source